The Indices of Cardiovascular Magnetic Resonance Derived Atrial Dynamics May Improve the Contemporary Risk

Lidia Ziółkowska1, Łukasz Mazurkiewicz2, Joanna Petryka3

  • 1Department of Cardiology, The Children's Memorial Health Institute, 04-730 Warsaw, Poland.

Insights

A new algorithm, HCM Risk-Kids, accurately identifies children with hypertrophic cardiomyopathy (HCM) at high risk for adverse events. Including atrial dynamics further improved risk stratification for better primary prevention strategies.

Area of Science:

  • Pediatric Cardiology
  • Cardiovascular Research
  • Biomedical Engineering

Background:

  • Accurate risk stratification is crucial for identifying children with hypertrophic cardiomyopathy (HCM) at high risk for adverse events.
  • Existing algorithms require refinement for optimal primary prevention in pediatric HCM populations.

Purpose of the Study:

  • To compare the efficacy of current risk stratification algorithms in pediatric hypertrophic cardiomyopathy.
  • To investigate the added value of novel biatrial performance indices in improving risk prediction.

Main Methods:

  • Retrospective analysis of 55 children with HCM, evaluating classic ACC/AHA risk factors and the novel HCM Risk-Kids score.
  • Assessed prognostic utility of these scores alone and in combination with biatrial dynamics indices.
  • Defined endpoints as sudden cardiac death, cardiac arrest, or appropriate ICD discharge.

Main Results:

  • The HCM Risk-Kids score showed a trend towards better endpoint identification compared to the ACC/AHA strategy (DeLong p=0.08).
  • Incorporating atrial conduit function significantly enhanced prediction accuracy for both the ACC/AHA Model (DeLong p=0.01) and HCM Risk-Kids algorithm (DeLong p=0.04).
  • Seven children experienced endpoints, including four deaths and three appropriate ICD discharges.

Conclusions:

  • The HCM Risk-Kids algorithm provides accurate risk stratification for high-risk children with HCM.
  • The addition of atrial dynamic indices substantially improves risk stratification strategies in pediatric hypertrophic cardiomyopathy.
Abstract